DyeVert™ Plus Contrast Reduction System Multicenter Observational Study
Minimizing Radiographic Contrast Administration During Coronary Angiography Using a Novel Contrast Reduction System: A Multicenter Observational Study of the DyeVert™ Plus Contrast Reduction System
Sponsor: Osprey Medical, Inc
This observational or N/A phase trial investigates Chronic Kidney Disease and is currently completed. Osprey Medical, Inc leads this study, which shows 9 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2023 — Jul 2024 [monthly]
Completed
-
Dec 2022 — Jan 2023 [monthly]
Completed
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Feb 2020 — Nov 2020 [monthly]
Completed
-
Nov 2018 — Feb 2020 [monthly]
Completed
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Osprey Medical, Inc
For direct contact, visit the study record on ClinicalTrials.gov .